Global CALM Implementation Study

Titre officiel

Managing Cancer and Living Meaningfully (CALM): A Global Initiative

Sommaire:

Cette étude vise à évaluer la mise en œuvre du programme « Managing Cancer and Living Meaningfully » (CALM) dans divers contextes culturels, notamment sa faisabilité, sa fidélité au protocole et son acceptabilité. Elle évaluera également la généralisabilité interculturelle de l’intervention CALM en mettant l’accent sur les résultats signalés par les patients en ce qui concerne leur bien-être psychologique et leur qualité de vie.

Description de l'essai

Primary Outcome:

• Change in Site Feasibility Metrics
• Change in Confidence in Therapy - Oncology Questionnaire
• Change in Supervision Evaluation Questionnaire

CALM is a semi-structured, manualized, individual psychotherapy designed for patients with advanced cancer and their loved ones. Research conducted over the past decade has shown that CALM is a feasible, acceptable, and effective therapy for patients with advanced or metastatic cancer. The CALM Training Program was developed to train oncology clinicians in the delivery of CALM. The training program consists of: 1) introductory workshops, which provide foundational training in the intervention; 2) advanced workshops, which support the development of advanced therapeutic skills; and 3) ongoing case supervision, delivered in small-group format, either in-person or online, which provides an opportunity for continuing improvement and refinement in the delivery of CALM. To evaluate the implementation of the CALM Program at the clinician and organization levels, we will approach clinicians engaging in the CALM Training Program and invite them to participate in this research study, which includes completion of quantitative measures at baseline, 1 year (primary endpoint) and 2 years (study endpoint), participation in qualitative interviews, and collection of feasibility data. Implementation science frameworks will be applied to assess participants' perceived individual- and contextual-level barriers and facilitators to implementing CALM through qualitative interviews. Sites involved in the Global CALM Program will conduct pilot studies of CALM in their setting to evaluate CALM at the patient- and caregiver-levels. We will not be involved in the collection of prospective patient- and caregiver-level data, however data will be pooled and analyzed to assess the cross-cultural generalizability of the CALM intervention.

Voir cet essai sur ClinicalTrials.gov